摘要
Abstract
At present,global health governance is entering a new reforming stage on its rules.The adoption of Amendments to the International Health Regulations(2005)at the 77th World Health Assembly in 2024 and the adoption of the WHO Pandemic Agreement at the 78th World Health Assembly in 2025 have become important interim achievements of this round of reform.Developed countries have always played a dominant role in rule-making in global health governance.In this round of reform,competition between developed and developing countries is becoming increasingly fierce,and developing countries including China are faced with significant challenges in playing their due roles in global health governance system.The key issues under dispute lie in genetic sequence data sharing,medical products availability,and international cooperation in core capacity building.United with other developing countries,China should make more constructive suggestions on advocating"conditional"sharing of genetic sequence date,promoting benefit-sharing obligations to be more substantive,and enhancing core capacity building of developing countries in the following reform process,promoting the construction of a human health community through practical actions.关键词
全球卫生治理/《国际卫生条例(2005)修正案》/《大流行协定》/构建人类卫生健康共同体Key words
global health governance/International Health Regulations(2005)/WHO Pandemic Agreement/construction of a human health community分类
社会科学
